<?xml version='1.0' encoding='UTF-8'?>
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article">
  <?properties open_access?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Nat Sci Sleep</journal-id>
      <journal-id journal-id-type="iso-abbrev">Nat Sci Sleep</journal-id>
      <journal-id journal-id-type="publisher-id">nss</journal-id>
      <journal-title-group>
        <journal-title>Nature and Science of Sleep</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1179-1608</issn>
      <publisher>
        <publisher-name>Dove</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">35478722</article-id>
      <article-id pub-id-type="pmc">9037722</article-id>
      <article-id pub-id-type="publisher-id">357586</article-id>
      <article-id pub-id-type="doi">10.2147/NSS.S357586</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Association of Excessive Daytime Sleepiness with Cerebral Small Vessel Disease in Community-Dwelling Older Adults</article-title>
        <alt-title alt-title-type="running-authors">Zhao et al</alt-title>
        <alt-title alt-title-type="running-title">Zhao et al</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Zhao</surname>
            <given-names>Jing</given-names>
          </name>
          <xref rid="aff0001" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kong</surname>
            <given-names>Qianqian</given-names>
          </name>
          <xref rid="aff0001" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>Minghuan</given-names>
          </name>
          <xref rid="aff0001" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Huang</surname>
            <given-names>Hao</given-names>
          </name>
          <xref rid="aff0001" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zhou</surname>
            <given-names>Xirui</given-names>
          </name>
          <xref rid="aff0001" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Guo</surname>
            <given-names>Yinping</given-names>
          </name>
          <xref rid="aff0001" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>Yi</given-names>
          </name>
          <xref rid="aff0001" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wu</surname>
            <given-names>Lingshan</given-names>
          </name>
          <xref rid="aff0001" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yu</surname>
            <given-names>Zhiyuan</given-names>
          </name>
          <xref rid="aff0001" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Luo</surname>
            <given-names>Xiang</given-names>
          </name>
          <xref rid="aff0001" ref-type="aff">1</xref>
          <xref rid="an0001" ref-type="corresp"/>
        </contrib>
        <aff id="aff0001"><label>1</label><institution>Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology</institution>, <addr-line>Wuhan</addr-line>, <addr-line>Hubei</addr-line>, <country>People’s Republic of China</country></aff>
      </contrib-group>
      <author-notes>
        <corresp id="an0001">Correspondence: Xiang Luo, <institution>Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology</institution>, <addr-line>Wuhan</addr-line>, <addr-line>430030</addr-line>, <country>People’s Republic of China</country>, <phone>Tel +86 27-83663337</phone>, Email flydottjh@163.com</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>21</day>
        <month>4</month>
        <year>2022</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2022</year>
      </pub-date>
      <volume>14</volume>
      <fpage>765</fpage>
      <lpage>773</lpage>
      <history>
        <date date-type="received">
          <day>08</day>
          <month>1</month>
          <year>2022</year>
        </date>
        <date date-type="accepted">
          <day>05</day>
          <month>4</month>
          <year>2022</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© 2022 Zhao et al.</copyright-statement>
        <copyright-year>2022</copyright-year>
        <copyright-holder>Zhao et al.</copyright-holder>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/3.0/</ali:license_ref>
          <license-p>This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at <ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link> and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (<ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link>).</license-p>
        </license>
      </permissions>
      <abstract>
        <sec id="s2001">
          <title>Purpose</title>
          <p><citation_analysis attribute="neither">Excessive daytime sleepiness (EDS) and cerebral small vessel disease (CSVD) are common problems among older adults; however, their association is not clear. The present study aimed to investigate the frequency of EDS in CSVD patients and the relationship between EDS and neuroimaging markers of CSVD.</citation_analysis></p>
        </sec>
        <sec id="s2002">
          <title>Patients and Methods</title>
          <p><citation_analysis attribute="positive">We conducted a cross-sectional study among 1076 community-dwelling older adults aged 55–85 years. EDS was measured using the Epworth Sleepiness Scale (ESS), and EDS was defined as an ESS score greater than 10. Binary logistic regression was performed to assess the association between EDS and neuroimaging markers of CSVD.</citation_analysis></p>
        </sec>
        <sec id="s2003">
          <title>Results</title>
          <p><citation_analysis attribute="neither">Of the 1076 participants (mean age: 65.58 ± 6.46 years, 60.5% female), the prevalence of EDS was 10.0%. EDS was more frequent in participants with CSVD than in the total sample (20.0% vs 10.0%, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">p</italic></citation_analysis><citation_analysis attribute="positive"> &lt;0.001). In fully adjusted models, EDS was significantly correlated with CSVD burden (OR = 1.39, 95% CI 1.16 to 1.68, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">p</italic></citation_analysis><citation_analysis attribute="neither"> &lt;0.001), the severity of white matter hyperintensities (WMH) (OR = 1.33, 95% CI 1.14 to 1.54, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">p</italic></citation_analysis><citation_analysis attribute="neither"> &lt;0.001), and presence of lacunes (OR = 2.47, 95% CI 1.53 to 4.00, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">p</italic></citation_analysis><citation_analysis attribute="neither"> &lt;0.001) but not with the presence of cerebral microbleeds (CMBs) (OR=1.54, 95% CI 0.92 to 2.56, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">p</italic></citation_analysis><citation_analysis attribute="neither"> = 0.099) or severity of enlarged perivascular spaces (EPVS) in basal ganglia (OR = 1.16, 95% CI 0.70 to 1.92, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">p</italic></citation_analysis><citation_analysis attribute="neither"> = 0.564).</citation_analysis></p>
        </sec>
        <sec id="s2004">
          <title>Conclusion</title>
          <p><citation_analysis attribute="positive">We found a high frequency of EDS symptoms in CSVD individuals. Further, EDS was significantly associated with WMH, lacunes, and CSVD burden. Our findings further suggest patients with CSVD may exhibit abnormal sleep-wake patterns.</citation_analysis></p>
        </sec>
      </abstract>
      <kwd-group kwd-group-type="author">
        <title>Keywords</title>
        <kwd>cerebral small vessel disease</kwd>
        <kwd>daytime sleepiness</kwd>
        <kwd>sleep disorders</kwd>
        <kwd>white matter hyperintensities</kwd>
        <kwd>lacunes</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>
<institution-wrap><institution>the National Nature Science Foundation of China</institution></institution-wrap>
</funding-source>
        </award-group>
        <award-group>
          <funding-source>
<institution-wrap><institution>Key Research and Development Program of Hubei Province</institution></institution-wrap>
</funding-source>
        </award-group>
        <award-group>
          <funding-source>
<institution-wrap><institution>the Application Foundation Frontier Special Project of Wuhan Science and Technology Bureau</institution></institution-wrap>
</funding-source>
        </award-group>
        <award-group>
          <funding-source>
<institution-wrap><institution>the Flagship Program of Tongji Hospital</institution></institution-wrap>
</funding-source>
        </award-group>
        <funding-statement>This study was supported by the National Nature Science Foundation of China (82171385 to X. Luo), Key Research and Development Program of Hubei Province (2020BCA070 to X. Luo), the Application Foundation Frontier Special Project of Wuhan Science and Technology Bureau (2020020601012226 to X. Luo), the Flagship Program of Tongji Hospital (2019CR106 to X. Luo).</funding-statement>
      </funding-group>
      <counts>
        <fig-count count="1"/>
        <table-count count="9"/>
        <ref-count count="55"/>
        <page-count count="9"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="s0001">
      <title>Introduction</title>
      <p><citation_analysis attribute="neither">Cerebral small vessel disease (CSVD) is common in the older population, and the incidence of CSVD increases with age.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0001" ref-type="bibr">1</xref></citation_analysis><citation_analysis attribute="neither"> CSVD is a progressive syndrome characterized by clinical, neuroimaging, and neuropathologic presentations related to the small vessels of the brain.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0002" ref-type="bibr">2</xref></citation_analysis><citation_analysis attribute="neither"> The primary neuroimaging markers of CSVD include recent small subcortical infarcts, lacunes, white matter hyperintensities (WMH), enlarged perivascular spaces (EPVS), cerebral microbleeds (CMBs), and atrophy.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0003" ref-type="bibr">3</xref></citation_analysis><citation_analysis attribute="neither"> The clinical manifestations of CSVD are heterogeneous. Clinically, CSVD is associated with stroke, cognitive impairment, gait dysfunction, mood disorders, and urinary disorders.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0002" ref-type="bibr">2</xref></citation_analysis><citation_analysis attribute="positive"> In recent years, growing evidence suggests that CSVD is also associated with sleep disorders.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0004" ref-type="bibr">4–8</xref></citation_analysis></p>
      <p><citation_analysis attribute="positive">Obstructive sleep apnea (OSA) is a common sleep-related breathing disorder and has been validated as an independent risk factor for stroke and ischemic heart disease.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0007" ref-type="bibr">7</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0009" ref-type="bibr">9</xref></citation_analysis><citation_analysis attribute="neither"> A meta-analysis including fourteen observational studies showed that OSA was associated with features of CSVD, specifically WMH and asymptomatic lacunar infarction (ALI).</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0006" ref-type="bibr">6</xref></citation_analysis><citation_analysis attribute="positive"> Prior work has also reported that CSVD is associated with other sleep disorders, like insomnia and periodic limb movements (PLM).</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0004" ref-type="bibr">4</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0005" ref-type="bibr">5</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0008" ref-type="bibr">8</xref></citation_analysis><citation_analysis attribute="neither"> For example, the occurrence of insomnia in older adults with CSVD is higher than that among general older adults,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0004" ref-type="bibr">4</xref></citation_analysis><citation_analysis attribute="neither"> and Kang et al found that the PLM index was positively correlated with neuroimaging markers of CSVD (eg, WMH, lacunes, EPVS).</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0008" ref-type="bibr">8</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">Excessive daytime sleepiness (EDS) is a common sleep symptom among older adults, and is a typical symptom of OSA.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0010" ref-type="bibr">10</xref></citation_analysis><citation_analysis attribute="neither"> EDS is defined as the inability to maintain wake and alertness during the major waking episodes of the day.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0011" ref-type="bibr">11</xref></citation_analysis><citation_analysis attribute="negative"> EDS may increase the risk of accidents and injuries (eg, motor vehicle crashes, work-related accidents) due to decreased alertness, and negatively influence cognition and quality of life.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0012" ref-type="bibr">12–14</xref></citation_analysis><citation_analysis attribute="neither"> Moreover, published summary data from cohort studies showed that EDS is associated with greater risks of cardiovascular disease (CVD) events, coronary heart disease, stroke, and all-cause mortality among older adults.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0011" ref-type="bibr">11</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0015" ref-type="bibr">15</xref></citation_analysis><citation_analysis attribute="neither"> Therefore, EDS is a major public health problem. Currently, studies have revealed that EDS is frequently associated with central nervous system (CNS) diseases, such as Alzheimer’s disease (AD), Parkinson’s disease (PD), headache, multiple sclerosis, and amyotrophic lateral sclerosis (ALS).</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0016" ref-type="bibr">16–19</xref></citation_analysis><citation_analysis attribute="neither"> However, to our knowledge, no study has focused on the association between neuroimaging markers of CSVD and EDS. Thus, the present study examined the prevalence of EDS in CSVD patients and investigated the association between EDS and neuroimaging makers of CSVD.</citation_analysis></p>
    </sec>
    <sec id="s0002">
      <title>Materials and Methods</title>
      <sec id="s0002-s2001">
        <title>Study Population</title>
        <p><citation_analysis attribute="neither">This study is an ongoing community-based study in older residents in Wuhan, China. Eligible residents aged 55 years or older and living in the communities of Wuhan were invited to participate in the study. Exclusion criteria for the present study include inability to live unaided; life expectancy less than 1 year; diagnosis of any neurodegenerative disease (eg, AD, PD); diagnosis of any psychiatric disease (eg, major depression, schizophrenia); stroke, trauma, or infection during the past 3 months; magnetic resonance imaging (MRI) contraindications; and failure to communicate and complete an interview due to any reasons.</citation_analysis></p>
        <p><citation_analysis attribute="positive">From November 2020 to October 2021, a total of 1177 community residents participated in the present study. All examinations such as brain MRI and cognitive assessment were completed within one day. This study was approved by the Institutional Review Board of Tongji Hospital (No. S105) and was carried out in accordance with the Declaration of Helsinki. All participants provided written informed consent.</citation_analysis></p>
      </sec>
      <sec id="s0002-s2002">
        <title>Sleep Assessment</title>
        <p><citation_analysis attribute="positive">EDS was assessed using the Epworth Sleepiness Scale (ESS) which consists of eight questions. The ESS score varies between 0 and 24. A higher score indicates a higher sleep propensity and a score &gt; 10 represents EDS.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0020" ref-type="bibr">20</xref></citation_analysis></p>
        <p><citation_analysis attribute="positive">Sleep quality over the past month was measured using the Pittsburgh Sleep Quality Index (PSQI), a questionnaire based on self-reported experiences. The PSQI consists of 19 items ranging from 0 to 21. A global PSQI score of 5 or more indicates poor sleep quality.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0021" ref-type="bibr">21</xref></citation_analysis></p>
        <p><citation_analysis attribute="positive">The potential risk of OSA was assessed using the STOP-Bang questionnaire, which includes eight items (snoring, tiredness, observed apnea, high blood pressure, body mass index, age, neck circumference, and gender). A score ≥ 3 indicates moderate-to-severe OSA.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0022" ref-type="bibr">22</xref></citation_analysis></p>
      </sec>
      <sec id="s0002-s2003">
        <title>Neuropsychological Assessment</title>
        <p><citation_analysis attribute="positive">All study participants underwent extensive neuropsychological testing, which included the following items: (1) neurocognitive screening assessments: Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA); (2) processing speed: Trail Making Test A (TMT-A), Stroop words, Stroop color; (3) executive function: Trail Making Test B (TMT-B), Stroop interference, Digit Span Test (backward), Verbal Fluency Test (VFT); (4) memory: Auditory Verbal Learning Test (AVLT); (5) language: Boston Naming Test (BNT).</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0023" ref-type="bibr">23</xref></citation_analysis><citation_analysis attribute="positive"> Performance in the four cognitive domains was made comparable by converting cognitive test scores to age, sex, and education adjusted z-scores.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0024" ref-type="bibr">24</xref></citation_analysis><citation_analysis attribute="positive">
</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">Z</italic></citation_analysis><citation_analysis attribute="neither"> scores for the TMT and Stroop were multiplied by −1 so that higher </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">z</italic></citation_analysis><citation_analysis attribute="neither"> scores indicate better performance.</citation_analysis></p>
      </sec>
      <sec id="s0002-s2004">
        <title>MRI Assessment</title>
        <p><citation_analysis attribute="positive">Brain MRI was obtained using a single 3T MRI scanner (United Imaging, Shanghai, China). Following predefined standardized protocols, the MRI included at least five sequences: T1-weighted, T2-weighted, fluid-attenuated inversion recovery (FLAIR), diffusion-weighted imaging (DWI), and susceptibility-weighted imaging (SWI) (see </citation_analysis><citation_analysis attribute="positive"><underline><ext-link xlink:href="https://www.dovepress.com/get_supplementary_file.php?f=357586.docx" ext-link-type="uri">Supplementary Table 1</ext-link></underline></citation_analysis><citation_analysis attribute="neither"> for detailed MRI protocols).</citation_analysis></p>
        <p><citation_analysis attribute="neither">Two trained radiologists, who were blinded to all the clinical data, rated the neuroimaging markers of CSVD based on the STandards for ReportIng Vascular changes on nEuroimaging (STRIVE) criteria.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0003" ref-type="bibr">3</xref></citation_analysis></p>
        <p><citation_analysis attribute="positive">Lacunes were defined as round or ovoid cerebrospinal fluid (CSF) containing cavities with a surrounding rim of hyperintensity in subcortical regions that range from 3 to 15 mm in diameter. The severity of the periventricular WMH (PWMH) and deep WMH (DWMH) was assessed using the Fazekas scale.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0025" ref-type="bibr">25</xref></citation_analysis><citation_analysis attribute="neither"> CMBs were defined as rounded hypointense lesions (2–10 mm in diameter) on SWI sequences. EPVS were defined as round, ovoid, or linear lesions, generally smaller than 3 mm in diameter with a CSF-like signal on all sequences. The severity of EPVS in the basal ganglia (BG) was rated according to the number of spaces in a unilateral slice containing the maximum EPVS: 0 = no EPVS, 1 = 1–10 EPVS, 2 = 11–20 EPVS, 3 = 21–40 EPVS, and 4 = 40 or more EPVS. EPVS score ≥ 2 in BG was defined as moderate-to-severe EPVS.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0026" ref-type="bibr">26</xref></citation_analysis></p>
        <p><citation_analysis attribute="positive">The total burden of the CSVD was evaluated using the total CSVD score (from 0 to 4 points). One point was awarded for any of the following: Fazekas score 3 for PWMH or 2–3 for DWMH, any lacune, any CMB, and EPVS score ≥ 2 in BG.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0027" ref-type="bibr">27</xref></citation_analysis></p>
        <p><citation_analysis attribute="neither">The presence of CSVD referred to a criterion previously published.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0028" ref-type="bibr">28</xref></citation_analysis><citation_analysis attribute="neither"> Participants with moderate to severe CSVD burden with a total CSVD score &gt; 1 were considered a part of the CSVD group. Participants in the CSVD group were then divided into EDS+ and EDS- subgroups based upon the presence or absence of EDS, respectively.</citation_analysis></p>
      </sec>
      <sec id="s0002-s2005">
        <title>Assessment of Other Variables</title>
        <p><citation_analysis attribute="positive">Age, sex, height, weight, education level, smoking, and alcohol consumption were recorded using a standardized questionnaire. Depressive symptoms were measured using the Hamilton Depression Rating Scale (HAMD).</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0029" ref-type="bibr">29</xref></citation_analysis><citation_analysis attribute="neither"> Participants’ self-reported medical history and medication use were also documented.</citation_analysis></p>
      </sec>
      <sec id="s0002-s2006">
        <title>Statistical Analysis</title>
        <p><citation_analysis attribute="positive">The data were analyzed using SPSS version 21.0 software (SPSS Inc., Chicago, IL, USA). The demographic variables of the participants are presented as mean (standard deviation), or frequency (percentage) when appropriate. The inter-group difference was compared using the Student’s t-tests (for continuous variables with a normal distribution), Mann–Whitney </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">U</italic></citation_analysis><citation_analysis attribute="neither">-tests (for continuous variables with a non-normal distribution), or </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">χ</italic></citation_analysis><citation_analysis attribute="positive"><sup>2</sup></citation_analysis><citation_analysis attribute="positive"> tests (for categorical variables). Binary logistic regressions were conducted to assess the association between EDS and neuroimaging markers of CSVD. Statistical models were initially adjusted for age and sex (Model 1) and then further adjusted for education level, smoking status, hypertension, diabetes, HAMD score, PSQI score, and a STOP-Bang score ≥ 3 (Model 2). In addition, we performed a stratified analysis according to diabetes status. A significance threshold of </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">p</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.05 was considered statistically significant.</citation_analysis></p>
      </sec>
    </sec>
    <sec id="s0003">
      <title>Results</title>
      <sec id="s0003-s2001">
        <title>Subject Characteristics</title>
        <p><citation_analysis attribute="positive">A total of 1076 participants were included in the final analyses. The flow chart of the present study is shown in </citation_analysis><citation_analysis attribute="positive"><xref rid="f0001" ref-type="fig">Figure 1</xref></citation_analysis><citation_analysis attribute="neither">. </citation_analysis><citation_analysis attribute="positive"><xref rid="t0001" ref-type="table">Table 1</xref></citation_analysis><citation_analysis attribute="neither"> shows the demographic and clinical data of the participants. The mean age of participants was 65.58 ± 6.46 years, and most participants were female (60.5%); 108 (10.0%) participants had EDS.</citation_analysis><citation_analysis attribute="positive"><table-wrap position="float" id="t0001"><label>Table 1</label><caption><p><citation_analysis attribute="neither">Characteristics of the Participants</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Variable</th><th rowspan="1" colspan="1">Total n = 1076</th><th rowspan="1" colspan="1">With EDS n = 108</th><th rowspan="1" colspan="1">Without EDS n = 968</th><th rowspan="1" colspan="1">P value</th><th rowspan="1" colspan="1">CSVD EDS+ n = 41</th><th rowspan="1" colspan="1">CSVD EDS- n = 164</th><th rowspan="1" colspan="1">P value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Age, years</td><td rowspan="1" colspan="1">65.58 ± 6.46</td><td rowspan="1" colspan="1">66.69 ± 6.61</td><td rowspan="1" colspan="1">65.46 ± 6.43</td><td rowspan="1" colspan="1">0.063</td><td rowspan="1" colspan="1">69.54 ± 7.06</td><td rowspan="1" colspan="1">69.12 ± 6.60</td><td rowspan="1" colspan="1">0.723</td></tr><tr><td rowspan="1" colspan="1">Male/Female</td><td rowspan="1" colspan="1">425/651</td><td rowspan="1" colspan="1">54/54</td><td rowspan="1" colspan="1">371/597</td><td rowspan="1" colspan="1">0.019<sup>a</sup></td><td rowspan="1" colspan="1">26/15</td><td rowspan="1" colspan="1">88/76</td><td rowspan="1" colspan="1">0.261</td></tr><tr><td rowspan="1" colspan="1">Education level, years</td><td rowspan="1" colspan="1">10.94 ± 3.58</td><td rowspan="1" colspan="1">10.36 ± 3.56</td><td rowspan="1" colspan="1">10.99 ± 3.57</td><td rowspan="1" colspan="1">0.097</td><td rowspan="1" colspan="1">9.71 ± 3.33</td><td rowspan="1" colspan="1">10.30 ± 3.74</td><td rowspan="1" colspan="1">0.295</td></tr><tr><td rowspan="1" colspan="1">BMI</td><td rowspan="1" colspan="1">23.73 ± 2.95</td><td rowspan="1" colspan="1">24.15 ± 3.12</td><td rowspan="1" colspan="1">23.68 ± 2.93</td><td rowspan="1" colspan="1">0.135</td><td rowspan="1" colspan="1">24.50 ± 2.40</td><td rowspan="1" colspan="1">24.03 ± 2.75</td><td rowspan="1" colspan="1">0.311</td></tr><tr><td rowspan="1" colspan="1">Current smoker, n (%)</td><td rowspan="1" colspan="1">133 (12.4%)</td><td rowspan="1" colspan="1">20 (18.5%)</td><td rowspan="1" colspan="1">113 (11.7%)</td><td rowspan="1" colspan="1">0.04<sup>a</sup></td><td rowspan="1" colspan="1">12 (29.3%)</td><td rowspan="1" colspan="1">32 (19.5%)</td><td rowspan="1" colspan="1">0.174</td></tr><tr><td rowspan="1" colspan="1">Current drinker, n (%)</td><td rowspan="1" colspan="1">116 (10.8%)</td><td rowspan="1" colspan="1">11 (10.2%)</td><td rowspan="1" colspan="1">105 (10.9%)</td><td rowspan="1" colspan="1">0.833</td><td rowspan="1" colspan="1">5 (12.2%)</td><td rowspan="1" colspan="1">21 (12.8%)</td><td rowspan="1" colspan="1">0.916</td></tr><tr><td rowspan="1" colspan="1">Comorbidities</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> Hypertension, n (%)</td><td rowspan="1" colspan="1">517 (48.1%)</td><td rowspan="1" colspan="1">65 (60.2%)</td><td rowspan="1" colspan="1">452 (46.7%)</td><td rowspan="1" colspan="1">0.008<sup>a</sup></td><td rowspan="1" colspan="1">31 (75.6%)</td><td rowspan="1" colspan="1">118 (72.0%)</td><td rowspan="1" colspan="1">0.638</td></tr><tr><td rowspan="1" colspan="1"> Diabetes, n (%)</td><td rowspan="1" colspan="1">223 (20.7%)</td><td rowspan="1" colspan="1">30 (27.8%)</td><td rowspan="1" colspan="1">193 (19.9%)</td><td rowspan="1" colspan="1">0.057</td><td rowspan="1" colspan="1">18 (43.9%)</td><td rowspan="1" colspan="1">33 (20.1%)</td><td rowspan="1" colspan="1">0.002<sup>b</sup></td></tr><tr><td rowspan="1" colspan="1"> Dyslipidemia, n (%)</td><td rowspan="1" colspan="1">293 (27.2%)</td><td rowspan="1" colspan="1">28 (25.9%)</td><td rowspan="1" colspan="1">265 (27.4%)</td><td rowspan="1" colspan="1">0.748</td><td rowspan="1" colspan="1">11 (26.8%)</td><td rowspan="1" colspan="1">51 (31.1%)</td><td rowspan="1" colspan="1">0.595</td></tr><tr><td rowspan="1" colspan="1">HAMD</td><td rowspan="1" colspan="1">3.42 ± 2.47</td><td rowspan="1" colspan="1">4.56 ± 2.55</td><td rowspan="1" colspan="1">3.29 ± 2.43</td><td rowspan="1" colspan="1">&lt;0.001<sup>a</sup></td><td rowspan="1" colspan="1">4.29 ± 2.69</td><td rowspan="1" colspan="1">3.21 ± 2.43</td><td rowspan="1" colspan="1">0.015<sup>b</sup></td></tr><tr><td rowspan="1" colspan="1">PSQI</td><td rowspan="1" colspan="1">6.70 ± 3.87</td><td rowspan="1" colspan="1">8.83 ± 4.10</td><td rowspan="1" colspan="1">6.46 ± 3.77</td><td rowspan="1" colspan="1">&lt;0.001<sup>a</sup></td><td rowspan="1" colspan="1">9.37 ± 4.56</td><td rowspan="1" colspan="1">7.09 ± 3.67</td><td rowspan="1" colspan="1">0.004<sup>b</sup></td></tr><tr><td rowspan="1" colspan="1">ESS</td><td rowspan="1" colspan="1">5.73 ± 3.11</td><td rowspan="1" colspan="1">12.31 ± 1.51</td><td rowspan="1" colspan="1">5.00 ± 2.27</td><td rowspan="1" colspan="1">&lt;0.001<sup>a</sup></td><td rowspan="1" colspan="1">12.78 ± 1.82</td><td rowspan="1" colspan="1">5.74 ± 2.23</td><td rowspan="1" colspan="1">&lt;0.001<sup>b</sup></td></tr><tr><td rowspan="1" colspan="1">STOP-Bang scores ≥3, n (%)</td><td rowspan="1" colspan="1">528 (49.1%)</td><td rowspan="1" colspan="1">80 (74.1%)</td><td rowspan="1" colspan="1">448 (46.3%)</td><td rowspan="1" colspan="1">&lt;0.001<sup>a</sup></td><td rowspan="1" colspan="1">36 (87.8%)</td><td rowspan="1" colspan="1">112 (68.3%)</td><td rowspan="1" colspan="1">0.013<sup>b</sup></td></tr><tr><td rowspan="1" colspan="1">Sleep medication use, n (%)</td><td rowspan="1" colspan="1">56 (5.2%)</td><td rowspan="1" colspan="1">5 (4.6%)</td><td rowspan="1" colspan="1">51 (5.3%)</td><td rowspan="1" colspan="1">0.777</td><td rowspan="1" colspan="1">3 (7.3%)</td><td rowspan="1" colspan="1">10 (6.1%)</td><td rowspan="1" colspan="1">0.726</td></tr></tbody></table><table-wrap-foot><fn id="tfn0001"><p><citation_analysis attribute="positive"><bold>Notes</bold></citation_analysis><citation_analysis attribute="neither">: </citation_analysis><citation_analysis attribute="positive"><sup>a</sup></citation_analysis><citation_analysis attribute="neither">Significant difference between the EDS and without EDS groups; </citation_analysis><citation_analysis attribute="positive"><sup>b</sup></citation_analysis><citation_analysis attribute="neither">Significant difference between the CSVD EDS+ and without CSVD EDS- groups.</citation_analysis></p></fn><fn id="tfn0002"><p><citation_analysis attribute="positive"><bold>Abbreviations</bold></citation_analysis><citation_analysis attribute="neither">: EDS, excessive daytime sleepiness; CSVD, cerebral small vessel disease; BMI, body mass index; HAMD, Hamilton Depression Scale; PSQI, Pittsburgh Sleep Quality Index; ESS, Epworth Sleepiness Scale.</citation_analysis></p></fn></table-wrap-foot></table-wrap></citation_analysis><citation_analysis attribute="positive">
</citation_analysis><citation_analysis attribute="positive"><fig position="float" id="f0001" fig-type="figure"><label>Figure 1</label><caption><p><citation_analysis attribute="neither">Flow chart.</citation_analysis></p></caption><graphic xlink:href="NSS-14-765-g0001" content-type="print-only" position="float"/><attrib><bold>Abbreviations</bold>: MRI, magnetic resonance imaging; EDS, excessive daytime sleepiness.</attrib></fig></citation_analysis></p>
        <p><citation_analysis attribute="positive">Participants presenting with EDS were more likely to be male, current smokers, have hypertension, poorer sleep quality, greater depression, and a higher risk of moderate-to-severe OSA than participants without EDS (</citation_analysis><citation_analysis attribute="positive"><xref rid="t0001" ref-type="table">Table 1</xref></citation_analysis><citation_analysis attribute="neither">).</citation_analysis></p>
        <p><citation_analysis attribute="positive">Among neuroimaging markers of CSVD, the EDS group demonstrated more severe WMH (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">p</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.001), EPVS in BG (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">p</italic></citation_analysis><citation_analysis attribute="negative"> = 0.023), a higher risk of lacunes (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">p</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.001), CMBs (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">p</italic></citation_analysis><citation_analysis attribute="neither"> = 0.018), and a higher CSVD burden (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">p</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.001) compared to those without EDS (</citation_analysis><citation_analysis attribute="positive"><xref rid="t0002" ref-type="table">Table 2</xref></citation_analysis><citation_analysis attribute="neither">).</citation_analysis><citation_analysis attribute="positive"><table-wrap position="float" id="t0002"><label>Table 2</label><caption><p><citation_analysis attribute="neither">Cognitive and Neuroimaging Characteristics of the Participants</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Variable</th><th rowspan="1" colspan="1">Total n = 1076</th><th rowspan="1" colspan="1">With EDS n = 108</th><th rowspan="1" colspan="1">Without EDS n = 968</th><th rowspan="1" colspan="1">P value</th><th rowspan="1" colspan="1">CSVD EDS+ n = 41</th><th rowspan="1" colspan="1">CSVD EDS- n = 164</th><th rowspan="1" colspan="1">P value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Cognitive Evaluation</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> MMSE</td><td rowspan="1" colspan="1">27.82 ± 2.17</td><td rowspan="1" colspan="1">27.34 ± 2.27</td><td rowspan="1" colspan="1">27.87 ± 2.15</td><td rowspan="1" colspan="1">0.012</td><td rowspan="1" colspan="1">26.80 ± 2.88</td><td rowspan="1" colspan="1">27.37 ± 2.38</td><td rowspan="1" colspan="1">0.198</td></tr><tr><td rowspan="1" colspan="1"> MoCA</td><td rowspan="1" colspan="1">24.2 ± 3.37</td><td rowspan="1" colspan="1">23.24 ± 3.65</td><td rowspan="1" colspan="1">24.3 ± 3.32</td><td rowspan="1" colspan="1">0.003</td><td rowspan="1" colspan="1">22.07 ± 3.84</td><td rowspan="1" colspan="1">23.16 ± 3.36</td><td rowspan="1" colspan="1">0.074</td></tr><tr><td rowspan="1" colspan="1"> Processing speed<sup>a</sup></td><td rowspan="1" colspan="1">0 ± 0.78</td><td rowspan="1" colspan="1">−0.26 ± 0.91</td><td rowspan="1" colspan="1">0.03 ± 0.76</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">−0.60 ± 1.14</td><td rowspan="1" colspan="1">−0.23 ± 0.96</td><td rowspan="1" colspan="1">0.019</td></tr><tr><td rowspan="1" colspan="1"> Executive function<sup>a</sup></td><td rowspan="1" colspan="1">0 ± 0.67</td><td rowspan="1" colspan="1">−0.17 ± 0.81</td><td rowspan="1" colspan="1">0.02 ± 0.65</td><td rowspan="1" colspan="1">0.013</td><td rowspan="1" colspan="1">−0.48 ± 0.95</td><td rowspan="1" colspan="1">−0.18 ± 0.70</td><td rowspan="1" colspan="1">0.039</td></tr><tr><td rowspan="1" colspan="1"> Memory<sup>a</sup></td><td rowspan="1" colspan="1">0 ± 0.84</td><td rowspan="1" colspan="1">−0.12 ± 0.96</td><td rowspan="1" colspan="1">0.01 ± 0.82</td><td rowspan="1" colspan="1">0.173</td><td rowspan="1" colspan="1">−0.28 ± 1.11</td><td rowspan="1" colspan="1">−0.21 ± 0.74</td><td rowspan="1" colspan="1">0.663</td></tr><tr><td rowspan="1" colspan="1"> Language<sup>a</sup></td><td rowspan="1" colspan="1">0 ± 1.00</td><td rowspan="1" colspan="1">−0.08 ± 0.85</td><td rowspan="1" colspan="1">0.01 ± 1.02</td><td rowspan="1" colspan="1">0.101</td><td rowspan="1" colspan="1">−0.34 ± 0.84</td><td rowspan="1" colspan="1">−0.32 ± 1.03</td><td rowspan="1" colspan="1">0.488</td></tr><tr><td rowspan="1" colspan="1">Brain magnetic resonance</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> Total Fazekas score</td><td rowspan="1" colspan="1">2.09 ± 1.33</td><td rowspan="1" colspan="1">2.88 ± 1.63</td><td rowspan="1" colspan="1">2.01 ± 1.26</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">4.34 ± 1.28</td><td rowspan="1" colspan="1">3.77 ± 1.34</td><td rowspan="1" colspan="1">0.015</td></tr><tr><td rowspan="1" colspan="1"> Presence of lacunes, n (%)</td><td rowspan="1" colspan="1">178 (16.5%)</td><td rowspan="1" colspan="1">39 (36.1%)</td><td rowspan="1" colspan="1">139 (14.4%)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">32 (78.1%)</td><td rowspan="1" colspan="1">95 (57.9%)</td><td rowspan="1" colspan="1">0.018</td></tr><tr><td rowspan="1" colspan="1"> Presence of CMBs, n (%)</td><td rowspan="1" colspan="1">182 (16.9%)</td><td rowspan="1" colspan="1">27 (25.0%)</td><td rowspan="1" colspan="1">155 (16.0%)</td><td rowspan="1" colspan="1">0.018</td><td rowspan="1" colspan="1">24 (58.5%)</td><td rowspan="1" colspan="1">85 (51.8%)</td><td rowspan="1" colspan="1">0.441</td></tr><tr><td rowspan="1" colspan="1"> &gt;10 EPVS_BG, n (%)</td><td rowspan="1" colspan="1">202 (18.8%)</td><td rowspan="1" colspan="1">29 (26.9%)</td><td rowspan="1" colspan="1">173 (17.9%)</td><td rowspan="1" colspan="1">0.023</td><td rowspan="1" colspan="1">25 (61.0%)</td><td rowspan="1" colspan="1">109 (66.5%)</td><td rowspan="1" colspan="1">0.509</td></tr><tr><td rowspan="1" colspan="1"> CSVD burden</td><td rowspan="1" colspan="1">0.72 ± 1.05</td><td rowspan="1" colspan="1">1.29 ± 1.39</td><td rowspan="1" colspan="1">0.66 ± 0.98</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">2.88 ± 0.81</td><td rowspan="1" colspan="1">2.52 ± 0.70</td><td rowspan="1" colspan="1">0.006</td></tr></tbody></table><table-wrap-foot><fn id="tfn0003"><p><citation_analysis attribute="positive"><bold>Notes</bold></citation_analysis><citation_analysis attribute="neither">: </citation_analysis><citation_analysis attribute="positive"><sup>a</sup></citation_analysis><citation_analysis attribute="neither"> Z-scores. The performance in the four cognitive domains is presented as the compound z-scores.</citation_analysis></p></fn><fn id="tfn0004"><p><citation_analysis attribute="positive"><bold>Abbreviations</bold></citation_analysis><citation_analysis attribute="neither">: EDS, excessive daytime sleepiness; CSVD, cerebral small vessel disease; MMSE, Mini-Mental State Examination; MoCA, Montreal Cognitive Assessment; CMBs, cerebral microbleeds; EPVS, enlarged perivascular spaces; BG, basal ganglia.</citation_analysis></p></fn></table-wrap-foot></table-wrap></citation_analysis><citation_analysis attribute="positive">
</citation_analysis></p>
        <p><citation_analysis attribute="positive">Participants with EDS demonstrated lower global cognition (MMSE, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">p</italic></citation_analysis><citation_analysis attribute="neither"> = 0.012; MoCA, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">p</italic></citation_analysis><citation_analysis attribute="neither"> = 0.003), significantly worse performance on processing speed (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">p</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.001) and executive function (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">p</italic></citation_analysis><citation_analysis attribute="neither"> = 0.013) compared to participants without EDS, while no differences in memory (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">p</italic></citation_analysis><citation_analysis attribute="neither"> = 0.173) or language (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">p</italic></citation_analysis><citation_analysis attribute="neither"> = 0.101) were observed between groups (</citation_analysis><citation_analysis attribute="positive"><xref rid="t0002" ref-type="table">Table 2</xref></citation_analysis><citation_analysis attribute="neither">).</citation_analysis></p>
      </sec>
      <sec id="s0003-s2002">
        <title>Clinical Data of CSVD Participants with and without EDS</title>
        <p><citation_analysis attribute="neither">Of the 1076 participants, 205 participants met criteria for CSVD. Of the participants that met criteria for CSVD, 41 also met criteria for EDS (EDS+), while 164 did not (EDS-). The prevalence of EDS in the CSVD group was notably higher than that of our total sample (20.0% vs 10.0%, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">p</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.001).</citation_analysis></p>
        <p><citation_analysis attribute="negative">Within the CSVD group, EDS+ participants had a higher risk of diabetes (p = 0.002), moderate-to-severe OSA (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">p</italic></citation_analysis><citation_analysis attribute="neither"> = 0.013), poorer sleep quality (PSQI, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">p</italic></citation_analysis><citation_analysis attribute="neither"> = 0.004), and greater depressive symptoms (HAMD, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">p</italic></citation_analysis><citation_analysis attribute="neither"> = 0.015) compared to EDS- participants (</citation_analysis><citation_analysis attribute="positive"><xref rid="t0001" ref-type="table">Table 1</xref></citation_analysis><citation_analysis attribute="positive">). Regarding cognitive performance, the CSVD EDS+ group demonstrated poorer performance on measures of processing speed (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">p</italic></citation_analysis><citation_analysis attribute="neither"> = 0.019), and executive function (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">p</italic></citation_analysis><citation_analysis attribute="neither"> = 0.039) than the CSVD EDS- group (</citation_analysis><citation_analysis attribute="positive"><xref rid="t0002" ref-type="table">Table 2</xref></citation_analysis><citation_analysis attribute="negative">). In addition, the CSVD EDS+ group had a higher risk of lacunes (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">p</italic></citation_analysis><citation_analysis attribute="neither"> = 0.018), WMH (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">p</italic></citation_analysis><citation_analysis attribute="neither"> = 0.015) and CSVD burden (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">p</italic></citation_analysis><citation_analysis attribute="positive"> = 0.006) compared with CSVD EDS- group, while there was no significant difference in the presence of CMBs (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">p</italic></citation_analysis><citation_analysis attribute="neither"> = 0.441) and EPVS severity in BG (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">p</italic></citation_analysis><citation_analysis attribute="neither"> = 0.509) (</citation_analysis><citation_analysis attribute="positive"><xref rid="t0002" ref-type="table">Table 2</xref></citation_analysis><citation_analysis attribute="neither">).</citation_analysis></p>
      </sec>
      <sec id="s0003-s2003">
        <title>Associations Between EDS and CSVD Markers</title>
        <p><citation_analysis attribute="positive">Associations among CSVD neuroimaging markers and EDS are shown in </citation_analysis><citation_analysis attribute="positive"><xref rid="t0003" ref-type="table">Table 3</xref></citation_analysis><citation_analysis attribute="neither">. In our total sample, EDS was significantly correlated with CSVD burden (OR = 1.54, 95% CI 1.30 to 1.82, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">p</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.001), total Fazekas score (OR = 1.50, 95% CI 1.31 to 1.72, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">p</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.001), and presence of lacunes (OR = 3.05, 95% CI 1.95 to 4.77, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">p</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.001), but not with the presence of CMBs (OR = 1.58, 95% CI 0.98 to 2.54, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">p</italic></citation_analysis><citation_analysis attribute="neither"> = 0.061) or severity of EPVS in BG (OR = 1.48, 95% CI 0.92 to 2.38, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">p</italic></citation_analysis><citation_analysis attribute="neither"> = 0.108) (adjusted for age and sex). Further adjusting for education level, smoking status, hypertension, diabetes, HAMD score, PSQI score and a STOP-Bang score of ≥ 3 did not attenuate these associations. Additionally, results did not differ when stratifying for diabetes (</citation_analysis><citation_analysis attribute="positive"><underline><ext-link xlink:href="https://www.dovepress.com/get_supplementary_file.php?f=357586.docx" ext-link-type="uri">Supplementary Table 2</ext-link></underline></citation_analysis><citation_analysis attribute="neither">).</citation_analysis><citation_analysis attribute="positive"><table-wrap position="float" id="t0003"><label>Table 3</label><caption><p><citation_analysis attribute="neither">Association Between MRI Markers of CSVD and EDS</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th colspan="2" rowspan="1">Model 1</th><th colspan="2" rowspan="1">Model 2</th></tr><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">OR (95% CI)</th><th rowspan="1" colspan="1">P value</th><th rowspan="1" colspan="1">OR (95% CI)</th><th rowspan="1" colspan="1">P value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">CSVD burden</td><td rowspan="1" colspan="1">1.54 (1.30–1.82)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">1.39 (1.16–1.68)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Total Fazekas score</td><td rowspan="1" colspan="1">1.50 (1.31–1.72)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">1.33 (1.14–1.54)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Presence of lacunes</td><td rowspan="1" colspan="1">3.05 (1.95–4.77)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">2.47 (1.53–4.00)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Presence of CMBs</td><td rowspan="1" colspan="1">1.58 (0.98–2.54)</td><td rowspan="1" colspan="1">0.061</td><td rowspan="1" colspan="1">1.54 (0.92–2.56)</td><td rowspan="1" colspan="1">0.099</td></tr><tr><td rowspan="1" colspan="1">EPVS_BG</td><td rowspan="1" colspan="1">1.48 (0.92–2.38)</td><td rowspan="1" colspan="1">0.108</td><td rowspan="1" colspan="1">1.16 (0.70–1.92)</td><td rowspan="1" colspan="1">0.564</td></tr></tbody></table><table-wrap-foot><fn id="tfn0005"><p><citation_analysis attribute="positive"><bold>Notes</bold></citation_analysis><citation_analysis attribute="positive">: Model 1 was adjusted for age and sex. Model 2 was adjusted for age, sex, education level, smoking status, hypertension, diabetes, HAMD, PSQI, STOP-Bang ≥ 3.</citation_analysis></p></fn><fn id="tfn0006"><p><citation_analysis attribute="positive"><bold>Abbreviations</bold></citation_analysis><citation_analysis attribute="neither">: MRI, magnetic resonance imaging; CSVD, cerebral small vessel disease; EDS, excessive daytime sleepiness; OR, odds ratio; CI, confidence interval; CMBs, cerebral microbleeds; EPVS, enlarged perivascular spaces; BG, basal ganglia.</citation_analysis></p></fn></table-wrap-foot></table-wrap></citation_analysis><citation_analysis attribute="positive">
</citation_analysis></p>
      </sec>
    </sec>
    <sec id="s0004">
      <title>Discussion</title>
      <p><citation_analysis attribute="neither">To our knowledge, this is the first study to investigate the incidence of EDS in CSVD patients and the association between EDS and neuroimaging markers of CSVD. In this community-based study, we found that the prevalence of EDS in participants with CSVD was 20.0%, which was notably higher than that of our total sample (10.0%). Further, EDS was related to neuroimaging markers of CSVD, in particular, WMH and lacunes. However, no association between EDS and CMBs or EPVS was observed.</citation_analysis></p>
      <p><citation_analysis attribute="neither">Previous studies have revealed that patients with neurological diseases (eg, PD, AD, ALS) have a higher incidence of EDS than the general population.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0016" ref-type="bibr">16</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0018" ref-type="bibr">18</xref></citation_analysis><citation_analysis attribute="positive"> In the present study, participants with CSVD had a higher frequency of EDS compared to participants in the overall sample. The prevalence of EDS in our sample was 10.0%, which is similar to previously reported values in an Asian multi-ethnic population (9%).</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0030" ref-type="bibr">30</xref></citation_analysis><citation_analysis attribute="positive"> Several epidemiological studies demonstrate that the prevalence of EDS ranges from 5% to 30%.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0031" ref-type="bibr">31</xref></citation_analysis><citation_analysis attribute="positive"> The difference in prevalence rates may be partially explained by the difference in socio-demographic characteristics and cultural factors, which may have influenced the response to the questionnaire.</citation_analysis></p>
      <p><citation_analysis attribute="neither">Recently, the association between CSVD and circadian rhythm disruption has gained attention. Some studies have revealed that sleep disorders (insomnia, OSA, PLM),</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0004" ref-type="bibr">4–8</xref></citation_analysis><citation_analysis attribute="neither"> abnormal circadian blood pressure (BP) (non-dipping, reverse-dipping BP patterns),</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0032" ref-type="bibr">32</xref></citation_analysis><citation_analysis attribute="neither"> and disturbed 24-hour activity rhythms (interdaily instability, intradaily variability)</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0033" ref-type="bibr">33</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0034" ref-type="bibr">34</xref></citation_analysis><citation_analysis attribute="positive"> are correlated with neuroimaging markers of CSVD. EDS represents one of the clinical symptoms of circadian rhythm disruption. Results from the present study demonstrate that EDS is associated with greater CSVD burden, WMH severity, and lacunes. These associations persist after controlling for potential confounders. In summary, our study provides new clinical evidence for the existence of circadian rhythm disruption in CSVD patients.</citation_analysis></p>
      <p><citation_analysis attribute="neither">Although the present study revealed a relationship between CSVD and EDS, the underlying pathophysiology is unclear. WMH in cholinergic pathways may affect the integrity of the adjacent medial cholinergic pathways.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0035" ref-type="bibr">35</xref></citation_analysis><citation_analysis attribute="neither"> An autopsy study in a patient with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) showed that cortical cholinergic projections from the nucleus basalis of Meynert (nbM) could be influenced by white matter lesions.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0036" ref-type="bibr">36</xref></citation_analysis><citation_analysis attribute="neither"> Most cholinergic input into the cerebral cortex originates from the nbM (in the basal forebrain).</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0037" ref-type="bibr">37</xref></citation_analysis><citation_analysis attribute="neither"> The majority of these cholinergic axons are unmyelinated; therefore, they may be more vulnerable to aging or damage in WM.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0035" ref-type="bibr">35</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0038" ref-type="bibr">38</xref></citation_analysis><citation_analysis attribute="neither"> The presence of lacunes is mainly located in the thalamus, basal ganglia, or frontal white matter,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0039" ref-type="bibr">39</xref></citation_analysis><citation_analysis attribute="neither"> and thus may affect the integrity of cholinergic pathways. The basal forebrain cholinergic system is involved in regulating the sleep-wake cycle.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0040" ref-type="bibr">40</xref></citation_analysis><citation_analysis attribute="neither"> We thus speculated that EDS may be due to impairments caused by CSVD in the cholinergic system.</citation_analysis></p>
      <p><citation_analysis attribute="neither">CSVD is associated with cognitive decline and the subsequent development of dementia.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0041" ref-type="bibr">41</xref></citation_analysis><citation_analysis attribute="neither"> A meta-analysis of prospective studies observed that WMH was associated with decline in global cognitive performance, processing speed, and executive function.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0042" ref-type="bibr">42</xref></citation_analysis><citation_analysis attribute="neither"> CMBs and EPVS were also associated with cognitive decline.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0043" ref-type="bibr">43–45</xref></citation_analysis><citation_analysis attribute="neither"> The specific mechanism of cognitive decline in CSVD patients is unclear but may be related to the disruption of cortical-subcortical networks.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0046" ref-type="bibr">46</xref></citation_analysis><citation_analysis attribute="neither"> Interestingly, a growing body of research suggests an association between EDS and cognitive impairment.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0015" ref-type="bibr">15</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0047" ref-type="bibr">47</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0048" ref-type="bibr">48</xref></citation_analysis><citation_analysis attribute="neither"> A longitudinal study showed that EDS was associated with cognitive decline 4 years later in a community-dwelling older population.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0049" ref-type="bibr">49</xref></citation_analysis><citation_analysis attribute="positive"> In the present study, CSVD patients with EDS demonstrated worse cognitive performance, especially regarding measures of processing speed and executive function, compared to CSVD patients without EDS. The mechanism for the effect of EDS on cognitive impairment in patients with CSVD is currently unknown. Thus, further studies are needed to extend and confirm these preliminary findings.</citation_analysis></p>
      <p><citation_analysis attribute="neither">EDS is highly prevalent in older adults. Unfortunately, EDS is frequently overlooked because it is considered a part of normal aging.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0010" ref-type="bibr">10</xref></citation_analysis><citation_analysis attribute="neither"> EDS is associated with many adverse outcomes, including cardiovascular diseases and mortality.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0012" ref-type="bibr">12</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0050" ref-type="bibr">50</xref></citation_analysis><citation_analysis attribute="positive"> CSVD is a slowly progressive disease, and patients with CSVD are often asymptomatic, making them less likely to be aware of the insidious disease progression.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0051" ref-type="bibr">51</xref></citation_analysis><citation_analysis attribute="negative"> Individuals with asymptomatic CSVD may develop various clinical syndromes (eg, stroke, dementia, mood disorders), which may increase the risk of mortality.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0052" ref-type="bibr">52</xref></citation_analysis><citation_analysis attribute="neither"> The present study found that EDS was associated with neuroimaging markers of CSVD, and CSVD patients with EDS showed worse cognitive performance. Given that EDS is a potential low-cost biomarker, it is necessary to perform EDS screenings, assessments, and treatments among community-dwelling older adults.</citation_analysis></p>
      <p><citation_analysis attribute="positive">The strengths of the current study include a large sample size of community-dwelling older adults, comprehensive evaluation of CSVD markers, and neuropsychological assessments. However, the present study has several limitations. First, the nature of a cross-sectional study limits causal inferences. Further, prospective or interventional studies are needed to clarify the relationship between CSVD and EDS. Second, due to the fact that sleep disorders were assessed only by self-reported questionnaires without polysomnography or actigraphy, subjective bias may exist in sleep assessment. However, it is difficult to perform objective sleep measures in a relatively large population-based study. Third, this study is limited to the Chinese population, and therefore may not be generalizable to other populations.</citation_analysis></p>
    </sec>
    <sec id="s0005">
      <title>Conclusion</title>
      <p><citation_analysis attribute="positive">Overall, findings from the present study suggest a high frequency of EDS symptoms in CSVD individuals. Further, EDS was significantly associated with a greater presence of WMH and lacunes but was not associated with CMBs and EPVS. Our findings suggest that older adults with CSVD may exhibit abnormal sleep-wake patterns, expanding the clinical spectrum of CSVD. Finally, prospective studies are necessary to assess the direction of the relationship between EDS and CSVD.</citation_analysis></p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgments</title>
      <p><citation_analysis attribute="neither">The authors thank all participating subjects.</citation_analysis></p>
    </ack>
    <sec id="s0006">
      <title>Abbreviations</title>
      <p><citation_analysis attribute="neither">EDS, excessive daytime sleepiness; CSVD, cerebral small vessel disease; ESS, Epworth Sleepiness Scale; OR, odds ratio; CI, confidence interval; WMH, white matter hyperintensities; CMBs, cerebral microbleeds; EPVS, enlarged perivascular spaces; OSA, obstructive sleep apnea; PLM, periodic limb movements; CNS, central nervous system; AD, Alzheimer’s disease; PD, Parkinson’s disease; ALS, amyotrophic lateral sclerosis; MRI, magnetic resonance imaging; PSQI, Pittsburgh Sleep Quality Index; MMSE, Mini-Mental State Examination; MoCA, Montreal Cognitive Assessment; TMT-A, Trail Making Test A; TMT-B, Trail Making Test B; VFT, Verbal Fluency Test; AVLT, Auditory Verbal Learning Test; BNT, Boston Naming Test; FLAIR, fluid-attenuated inversion recovery; DWI, diffusion-weighted imaging; SWI, susceptibility-weighted imaging; STRIVE, STandards for ReportIng Vascular changes on nEuroimaging; CSF, cerebrospinal fluid; PWMH, periventricular white matter hyperintensities; DWMH, deep white matter hyperintensities; BG, basal ganglia; HAMD, Hamilton Depression Rating Scale; CADASIL, cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy; nbM, nucleus basalis of Meynert.</citation_analysis></p>
    </sec>
    <sec sec-type="COI-statement" id="s0007">
      <title>Disclosure</title>
      <p><citation_analysis attribute="neither">The authors declare no conflicts of interest for this work.</citation_analysis></p>
    </sec>
    <ref-list>
      <title>References</title>
      <ref id="cit0001">
        <label>1.</label>
        <mixed-citation publication-type="journal"><string-name><surname>de Leeuw</surname>
<given-names>FE</given-names></string-name>, <string-name><surname>de Groot</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>Achten</surname>
<given-names>E</given-names></string-name>, et al. <article-title>Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study</article-title>. <source><italic toggle="yes">J Neurol Neurosurg Psychiatry</italic></source>. <year>2001</year>;<volume>70</volume>(<issue>1</issue>):<fpage>9</fpage>–<lpage>14</lpage>. doi:<pub-id pub-id-type="doi">10.1136/jnnp.70.1.9</pub-id><pub-id pub-id-type="pmid">11118240</pub-id></mixed-citation>
      </ref>
      <ref id="cit0002">
        <label>2.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Wardlaw</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Smith</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Dichgans</surname>
<given-names>M</given-names></string-name>. <article-title>Small vessel disease: mechanisms and clinical implications</article-title>. <source><italic toggle="yes">Lancet Neurol</italic></source>. <year>2019</year>;<volume>18</volume>(<issue>7</issue>):<fpage>684</fpage>–<lpage>696</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S1474-4422(19)30079-1</pub-id><pub-id pub-id-type="pmid">31097385</pub-id></mixed-citation>
      </ref>
      <ref id="cit0003">
        <label>3.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Wardlaw</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Smith</surname>
<given-names>EE</given-names></string-name>, <string-name><surname>Biessels</surname>
<given-names>GJ</given-names></string-name>, et al. <article-title>Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration</article-title>. <source><italic toggle="yes">Lancet Neurol</italic></source>. <year>2013</year>;<volume>12</volume>(<issue>8</issue>):<fpage>822</fpage>–<lpage>838</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S1474-4422(13)70124-8</pub-id><pub-id pub-id-type="pmid">23867200</pub-id></mixed-citation>
      </ref>
      <ref id="cit0004">
        <label>4.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Wang</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Liao</surname>
<given-names>J</given-names></string-name>, et al. <article-title>The influence of non-breathing-related sleep fragmentation on cognitive function in patients with cerebral small vessel disease</article-title>. <source><italic toggle="yes">Neuropsychiatr Dis Treat</italic></source>. <year>2019</year>;<volume>15</volume>:<fpage>1009</fpage>–<lpage>1014</lpage>. doi:<pub-id pub-id-type="doi">10.2147/NDT.S193869</pub-id><pub-id pub-id-type="pmid">31114207</pub-id></mixed-citation>
      </ref>
      <ref id="cit0005">
        <label>5.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Del Brutto</surname>
<given-names>OH</given-names></string-name>, <string-name><surname>Mera</surname>
<given-names>RM</given-names></string-name>, <string-name><surname>Zambrano</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Lama</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Del Brutto</surname>
<given-names>VJ</given-names></string-name>, <string-name><surname>Castillo</surname>
<given-names>PR</given-names></string-name>. <article-title>Poor sleep quality and silent markers of cerebral small vessel disease: a population-based study in community-dwelling older adults (The Atahualpa Project)</article-title>. <source><italic toggle="yes">Sleep Med</italic></source>. <year>2015</year>;<volume>16</volume>(<issue>3</issue>):<fpage>428</fpage>–<lpage>431</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.sleep.2014.10.023</pub-id><pub-id pub-id-type="pmid">25681211</pub-id></mixed-citation>
      </ref>
      <ref id="cit0006">
        <label>6.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Chokesuwattanaskul</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Lertjitbanjong</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Thongprayoon</surname>
<given-names>C</given-names></string-name>, et al. <article-title>Impact of obstructive sleep apnea on silent cerebral small vessel disease: a systematic review and meta-analysis</article-title>. <source><italic toggle="yes">Sleep Med</italic></source>. <year>2020</year>;<volume>68</volume>:<fpage>80</fpage>–<lpage>88</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.sleep.2019.11.1262</pub-id><pub-id pub-id-type="pmid">32028230</pub-id></mixed-citation>
      </ref>
      <ref id="cit0007">
        <label>7.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Del Brutto</surname>
<given-names>OH</given-names></string-name>, <string-name><surname>Mera</surname>
<given-names>RM</given-names></string-name>, <string-name><surname>Zambrano</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Castillo</surname>
<given-names>PR</given-names></string-name>. <article-title>Relationship between obstructive sleep apnea and neuroimaging signatures of cerebral small vessel disease in community-dwelling older adults. The Atahualpa Project</article-title>. <source><italic toggle="yes">Sleep Med</italic></source>. <year>2017</year>;<volume>37</volume>:<fpage>10</fpage>–<lpage>12</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.sleep.2017.06.009</pub-id><pub-id pub-id-type="pmid">28899518</pub-id></mixed-citation>
      </ref>
      <ref id="cit0008">
        <label>8.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Kang</surname>
<given-names>MK</given-names></string-name>, <string-name><surname>Koo</surname>
<given-names>DL</given-names></string-name>, <string-name><surname>Shin</surname>
<given-names>JH</given-names></string-name>, <string-name><surname>Kwon</surname>
<given-names>HM</given-names></string-name>, <string-name><surname>Nam</surname>
<given-names>H</given-names></string-name>. <article-title>Association between periodic limb movements during sleep and cerebral small vessel disease</article-title>. <source><italic toggle="yes">Sleep Med</italic></source>. <year>2018</year>;<volume>51</volume>:<fpage>47</fpage>–<lpage>52</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.sleep.2018.06.018</pub-id><pub-id pub-id-type="pmid">30099351</pub-id></mixed-citation>
      </ref>
      <ref id="cit0009">
        <label>9.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Culebras</surname>
<given-names>A</given-names></string-name>. <article-title>Sleep, stroke and poststroke</article-title>. <source><italic toggle="yes">Neurol Clin</italic></source>. <year>2012</year>;<volume>30</volume>(<issue>4</issue>):<fpage>1275</fpage>–<lpage>1284</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ncl.2012.08.017</pub-id><pub-id pub-id-type="pmid">23099137</pub-id></mixed-citation>
      </ref>
      <ref id="cit0010">
        <label>10.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Crowley</surname>
<given-names>K</given-names></string-name>. <article-title>Sleep and sleep disorders in older adults</article-title>. <source><italic toggle="yes">Neuropsychol Rev</italic></source>. <year>2011</year>;<volume>21</volume>(<issue>1</issue>):<fpage>41</fpage>–<lpage>53</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11065-010-9154-6</pub-id><pub-id pub-id-type="pmid">21225347</pub-id></mixed-citation>
      </ref>
      <ref id="cit0011">
        <label>11.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Wang</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>Q</given-names></string-name>, <string-name><surname>Heizhati</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Yao</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Luo</surname>
<given-names>Q</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>N</given-names></string-name>. <article-title>Association between excessive daytime sleepiness and risk of cardiovascular disease and all-cause mortality: a systematic review and meta-analysis of Longitudinal Cohort Studies</article-title>. <source><italic toggle="yes">J Am Med Dir Assoc</italic></source>. <year>2020</year>;<volume>21</volume>(<issue>12</issue>):<fpage>1979</fpage>–<lpage>1985</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jamda.2020.05.023</pub-id><pub-id pub-id-type="pmid">32693994</pub-id></mixed-citation>
      </ref>
      <ref id="cit0012">
        <label>12.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Howard</surname>
<given-names>ME</given-names></string-name>, <string-name><surname>Desai</surname>
<given-names>AV</given-names></string-name>, <string-name><surname>Grunstein</surname>
<given-names>RR</given-names></string-name>, et al. <article-title>Sleepiness, sleep-disordered breathing, and accident risk factors in commercial vehicle drivers</article-title>. <source><italic toggle="yes">Am J Respir Crit Care Med</italic></source>. <year>2004</year>;<volume>170</volume>(<issue>9</issue>):<fpage>1014</fpage>–<lpage>1021</lpage>. doi:<pub-id pub-id-type="doi">10.1164/rccm.200312-1782OC</pub-id><pub-id pub-id-type="pmid">15317672</pub-id></mixed-citation>
      </ref>
      <ref id="cit0013">
        <label>13.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Boulos</surname>
<given-names>MI</given-names></string-name>, <string-name><surname>Murray</surname>
<given-names>BJ</given-names></string-name>. <article-title>Current evaluation and management of excessive daytime sleepiness</article-title>. <source><italic toggle="yes">Can J Neurol Sci</italic></source>. <year>2010</year>;<volume>37</volume>(<issue>2</issue>):<fpage>167</fpage>–<lpage>176</lpage>. doi:<pub-id pub-id-type="doi">10.1017/S0317167100009896</pub-id><pub-id pub-id-type="pmid">20437926</pub-id></mixed-citation>
      </ref>
      <ref id="cit0014">
        <label>14.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Okamura</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Ura</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Miyamae</surname>
<given-names>F</given-names></string-name>, et al. <article-title>Excessive daytime sleepiness is related to subjective memory impairment in late life: a cross-sectional community-based study</article-title>. <source><italic toggle="yes">Psychogeriatrics</italic></source>. <year>2016</year>;<volume>16</volume>(<issue>3</issue>):<fpage>196</fpage>–<lpage>201</lpage>. doi:<pub-id pub-id-type="doi">10.1111/psyg.12139</pub-id><pub-id pub-id-type="pmid">26179318</pub-id></mixed-citation>
      </ref>
      <ref id="cit0015">
        <label>15.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Newman</surname>
<given-names>AB</given-names></string-name>, <string-name><surname>Spiekerman</surname>
<given-names>CF</given-names></string-name>, <string-name><surname>Enright</surname>
<given-names>P</given-names></string-name>, et al.; <collab>The Cardiovascular Health Study Research Group</collab>. <article-title>Daytime sleepiness predicts mortality and cardiovascular disease in older adults</article-title>. <source><italic toggle="yes">J Am Geriatr Soc</italic></source>. <year>2000</year>;<volume>48</volume>(<issue>2</issue>):<fpage>115</fpage>–<lpage>123</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1532-5415.2000.tb03901.x</pub-id><pub-id pub-id-type="pmid">10682939</pub-id></mixed-citation>
      </ref>
      <ref id="cit0016">
        <label>16.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Maestri</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Romigi</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Schirru</surname>
<given-names>A</given-names></string-name>, et al. <article-title>Excessive daytime sleepiness and fatigue in neurological disorders</article-title>. <source><italic toggle="yes">Sleep Breath</italic></source>. <year>2020</year>;<volume>24</volume>(<issue>2</issue>):<fpage>413</fpage>–<lpage>424</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11325-019-01921-4</pub-id><pub-id pub-id-type="pmid">31444679</pub-id></mixed-citation>
      </ref>
      <ref id="cit0017">
        <label>17.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Bonanni</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Maestri</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Tognoni</surname>
<given-names>G</given-names></string-name>, et al. <article-title>Daytime sleepiness in mild and moderate Alzheimer’s disease and its relationship with cognitive impairment</article-title>. <source><italic toggle="yes">J Sleep Res</italic></source>. <year>2005</year>;<volume>14</volume>(<issue>3</issue>):<fpage>311</fpage>–<lpage>317</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1365-2869.2005.00462.x</pub-id><pub-id pub-id-type="pmid">16120107</pub-id></mixed-citation>
      </ref>
      <ref id="cit0018">
        <label>18.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Liu</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Huang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Tai</surname>
<given-names>H</given-names></string-name>, et al. <article-title>Excessive daytime sleepiness in Chinese patients with sporadic amyotrophic lateral sclerosis and its association with cognitive and behavioural impairments</article-title>. <source><italic toggle="yes">J Neurol Neurosurg Psychiatry</italic></source>. <year>2018</year>;<volume>89</volume>(<issue>10</issue>):<fpage>1038</fpage>–<lpage>1043</lpage>. doi:<pub-id pub-id-type="doi">10.1136/jnnp-2018-318810</pub-id><pub-id pub-id-type="pmid">30045943</pub-id></mixed-citation>
      </ref>
      <ref id="cit0019">
        <label>19.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Simuni</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Caspell-Garcia</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Coffey</surname>
<given-names>C</given-names></string-name>, et al. <article-title>Correlates of excessive daytime sleepiness in de novo Parkinson’s disease: a case control study</article-title>. <source><italic toggle="yes">Mov Disord</italic></source>. <year>2015</year>;<volume>30</volume>(<issue>10</issue>):<fpage>1371</fpage>–<lpage>1381</lpage>. doi:<pub-id pub-id-type="doi">10.1002/mds.26248</pub-id><pub-id pub-id-type="pmid">26095202</pub-id></mixed-citation>
      </ref>
      <ref id="cit0020">
        <label>20.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Johns</surname>
<given-names>MW</given-names></string-name>. <article-title>A new method for measuring daytime sleepiness: the Epworth sleepiness scale</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>1991</year>;<volume>14</volume>(<issue>6</issue>):<fpage>540</fpage>–<lpage>545</lpage>. doi:<pub-id pub-id-type="doi">10.1093/sleep/14.6.540</pub-id><pub-id pub-id-type="pmid">1798888</pub-id></mixed-citation>
      </ref>
      <ref id="cit0021">
        <label>21.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Buysse</surname>
<given-names>DJ</given-names></string-name>, <string-name><surname>Reynolds</surname>
<given-names>CF</given-names>
<suffix>3rd</suffix></string-name>, <string-name><surname>Monk</surname>
<given-names>TH</given-names></string-name>, <string-name><surname>Berman</surname>
<given-names>SR</given-names></string-name>, <string-name><surname>Kupfer</surname>
<given-names>DJ</given-names></string-name>. <article-title>The pittsburgh sleep quality index: a new instrument for psychiatric practice and research</article-title>. <source><italic toggle="yes">Psychiatry Res</italic></source>. <year>1989</year>;<volume>28</volume>(<issue>2</issue>):<fpage>193</fpage>–<lpage>213</lpage>. doi:<pub-id pub-id-type="doi">10.1016/0165-1781(89)90047-4</pub-id><pub-id pub-id-type="pmid">2748771</pub-id></mixed-citation>
      </ref>
      <ref id="cit0022">
        <label>22.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Chung</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Yegneswaran</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Liao</surname>
<given-names>P</given-names></string-name>, et al. <article-title>STOP questionnaire: a tool to screen patients for obstructive sleep apnea</article-title>. <source><italic toggle="yes">Anesthesiology</italic></source>. <year>2008</year>;<volume>108</volume>(<issue>5</issue>):<fpage>812</fpage>–<lpage>821</lpage>. doi:<pub-id pub-id-type="doi">10.1097/ALN.0b013e31816d83e4</pub-id><pub-id pub-id-type="pmid">18431116</pub-id></mixed-citation>
      </ref>
      <ref id="cit0023">
        <label>23.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Zhu</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Huang</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>S</given-names></string-name>, et al. <article-title>Cortical and subcortical grey matter abnormalities in white matter hyperintensities and subsequent cognitive impairment</article-title>. <source><italic toggle="yes">Neurosci Bull</italic></source>. <year>2021</year>;<volume>37</volume>(<issue>6</issue>):<fpage>789</fpage>–<lpage>803</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s12264-021-00657-0</pub-id><pub-id pub-id-type="pmid">33826095</pub-id></mixed-citation>
      </ref>
      <ref id="cit0024">
        <label>24.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Rijnen</surname>
<given-names>SJM</given-names></string-name>, <string-name><surname>Meskal</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Emons</surname>
<given-names>WHM</given-names></string-name>, et al. <article-title>Evaluation of normative data of a widely used computerized neuropsychological battery: applicability and effects of sociodemographic variables in a dutch sample</article-title>. <source><italic toggle="yes">Assessment</italic></source>. <year>2020</year>;<volume>27</volume>(<issue>2</issue>):<fpage>373</fpage>–<lpage>383</lpage>. doi:<pub-id pub-id-type="doi">10.1177/1073191117727346</pub-id><pub-id pub-id-type="pmid">28895436</pub-id></mixed-citation>
      </ref>
      <ref id="cit0025">
        <label>25.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Fazekas</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Chawluk</surname>
<given-names>JB</given-names></string-name>, <string-name><surname>Alavi</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Hurtig</surname>
<given-names>HI</given-names></string-name>, <string-name><surname>Zimmerman</surname>
<given-names>RA</given-names></string-name>. <article-title>MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging</article-title>. <source><italic toggle="yes">AJR Am J Roentgenol</italic></source>. <year>1987</year>;<volume>149</volume>(<issue>2</issue>):<fpage>351</fpage>–<lpage>356</lpage>. doi:<pub-id pub-id-type="doi">10.2214/ajr.149.2.351</pub-id><pub-id pub-id-type="pmid">3496763</pub-id></mixed-citation>
      </ref>
      <ref id="cit0026">
        <label>26.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Doubal</surname>
<given-names>FN</given-names></string-name>, <string-name><surname>MacLullich</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Ferguson</surname>
<given-names>KJ</given-names></string-name>, <string-name><surname>Dennis</surname>
<given-names>MS</given-names></string-name>, <string-name><surname>Wardlaw</surname>
<given-names>JM</given-names></string-name>. <article-title>Enlarged perivascular spaces on MRI are a feature of cerebral small vessel disease</article-title>. <source><italic toggle="yes">Stroke</italic></source>. <year>2010</year>;<volume>41</volume>(<issue>3</issue>):<fpage>450</fpage>–<lpage>454</lpage>. doi:<pub-id pub-id-type="doi">10.1161/STROKEAHA.109.564914</pub-id><pub-id pub-id-type="pmid">20056930</pub-id></mixed-citation>
      </ref>
      <ref id="cit0027">
        <label>27.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Staals</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Makin</surname>
<given-names>SD</given-names></string-name>, <string-name><surname>Doubal</surname>
<given-names>FN</given-names></string-name>, <string-name><surname>Dennis</surname>
<given-names>MS</given-names></string-name>, <string-name><surname>Wardlaw</surname>
<given-names>JM</given-names></string-name>. <article-title>Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden</article-title>. <source><italic toggle="yes">Neurology</italic></source>. <year>2014</year>;<volume>83</volume>(<issue>14</issue>):<fpage>1228</fpage>–<lpage>1234</lpage>. doi:<pub-id pub-id-type="doi">10.1212/WNL.0000000000000837</pub-id><pub-id pub-id-type="pmid">25165388</pub-id></mixed-citation>
      </ref>
      <ref id="cit0028">
        <label>28.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Amier</surname>
<given-names>RP</given-names></string-name>, <string-name><surname>Marcks</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Hooghiemstra</surname>
<given-names>AM</given-names></string-name>, et al. <article-title>Hypertensive exposure markers by MRI in relation to cerebral small vessel disease and cognitive impairment</article-title>. <source><italic toggle="yes">JACC Cardiovasc Imaging</italic></source>. <year>2021</year>;<volume>14</volume>(<issue>1</issue>):<fpage>176</fpage>–<lpage>185</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jcmg.2020.06.040</pub-id><pub-id pub-id-type="pmid">33011127</pub-id></mixed-citation>
      </ref>
      <ref id="cit0029">
        <label>29.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Hamilton</surname>
<given-names>M</given-names></string-name>. <article-title>A rating scale for depression</article-title>. <source><italic toggle="yes">J Neurol Neurosurg Psychiatry</italic></source>. <year>1960</year>;<volume>23</volume>:<fpage>56</fpage>–<lpage>62</lpage>. doi:<pub-id pub-id-type="doi">10.1136/jnnp.23.1.56</pub-id><pub-id pub-id-type="pmid">14399272</pub-id></mixed-citation>
      </ref>
      <ref id="cit0030">
        <label>30.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Ng</surname>
<given-names>TP</given-names></string-name>, <string-name><surname>Tan</surname>
<given-names>WC</given-names></string-name>. <article-title>Prevalence and determinants of excessive daytime sleepiness in an Asian multi-ethnic population</article-title>. <source><italic toggle="yes">Sleep Med</italic></source>. <year>2005</year>;<volume>6</volume>(<issue>6</issue>):<fpage>523</fpage>–<lpage>529</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.sleep.2005.01.007</pub-id><pub-id pub-id-type="pmid">16271696</pub-id></mixed-citation>
      </ref>
      <ref id="cit0031">
        <label>31.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Jaussent</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Morin</surname>
<given-names>CM</given-names></string-name>, <string-name><surname>Ivers</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Dauvilliers</surname>
<given-names>Y</given-names></string-name>. <article-title>Natural history of excessive daytime sleepiness: a population-based 5-year longitudinal study</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2020</year>;<volume>43</volume>(<issue>3</issue>). doi:<pub-id pub-id-type="doi">10.1093/sleep/zsz249</pub-id></mixed-citation>
      </ref>
      <ref id="cit0032">
        <label>32.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Chokesuwattanaskul</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Cheungpasitporn</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Thongprayoon</surname>
<given-names>C</given-names></string-name>, et al. <article-title>Impact of circadian blood pressure pattern on silent cerebral small vessel disease: a systematic review and meta-analysis</article-title>. <source><italic toggle="yes">J Am Heart Assoc</italic></source>. <year>2020</year>;<volume>9</volume>(<issue>12</issue>):<fpage>e016299</fpage>. doi:<pub-id pub-id-type="doi">10.1161/JAHA.119.016299</pub-id><pub-id pub-id-type="pmid">32476573</pub-id></mixed-citation>
      </ref>
      <ref id="cit0033">
        <label>33.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Zuurbier</surname>
<given-names>LA</given-names></string-name>, <string-name><surname>Ikram</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Luik</surname>
<given-names>AI</given-names></string-name>, et al. <article-title>Cerebral small vessel disease is related to disturbed 24-h activity rhythms: a population-based study</article-title>. <source><italic toggle="yes">Eur J Neurol</italic></source>. <year>2015</year>;<volume>22</volume>(<issue>11</issue>):<fpage>1482</fpage>–<lpage>1487</lpage>. doi:<pub-id pub-id-type="doi">10.1111/ene.12775</pub-id><pub-id pub-id-type="pmid">26206535</pub-id></mixed-citation>
      </ref>
      <ref id="cit0034">
        <label>34.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Sommer</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Yu</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Schneider</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Bennett</surname>
<given-names>DA</given-names></string-name>, <string-name><surname>Buchman</surname>
<given-names>AS</given-names></string-name>, <string-name><surname>Lim</surname>
<given-names>ASP</given-names></string-name>. <article-title>Disrupted rest-activity rhythms and cerebral small vessel disease pathology in older adults</article-title>. <source><italic toggle="yes">Stroke</italic></source>. <year>2021</year>;<volume>52</volume>(<issue>7</issue>):<fpage>2427</fpage>–<lpage>2431</lpage>. doi:<pub-id pub-id-type="doi">10.1161/STROKEAHA.120.030870</pub-id><pub-id pub-id-type="pmid">33902300</pub-id></mixed-citation>
      </ref>
      <ref id="cit0035">
        <label>35.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Bohnen</surname>
<given-names>NI</given-names></string-name>, <string-name><surname>Muller</surname>
<given-names>ML</given-names></string-name>, <string-name><surname>Kuwabara</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Constantine</surname>
<given-names>GM</given-names></string-name>, <string-name><surname>Studenski</surname>
<given-names>SA</given-names></string-name>. <article-title>Age-associated leukoaraiosis and cortical cholinergic deafferentation</article-title>. <source><italic toggle="yes">Neurology</italic></source>. <year>2009</year>;<volume>72</volume>(<issue>16</issue>):<fpage>1411</fpage>–<lpage>1416</lpage>. doi:<pub-id pub-id-type="doi">10.1212/WNL.0b013e3181a187c6</pub-id><pub-id pub-id-type="pmid">19380700</pub-id></mixed-citation>
      </ref>
      <ref id="cit0036">
        <label>36.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Mesulam</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Siddique</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Cohen</surname>
<given-names>B</given-names></string-name>. <article-title>Cholinergic denervation in a pure multi-infarct state: observations on CADASIL</article-title>. <source><italic toggle="yes">Neurology</italic></source>. <year>2003</year>;<volume>60</volume>(<issue>7</issue>):<fpage>1183</fpage>–<lpage>1185</lpage>. doi:<pub-id pub-id-type="doi">10.1212/01.WNL.0000055927.22611.EB</pub-id><pub-id pub-id-type="pmid">12682331</pub-id></mixed-citation>
      </ref>
      <ref id="cit0037">
        <label>37.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Mesulam</surname>
<given-names>MM</given-names></string-name>, <string-name><surname>Geula</surname>
<given-names>C</given-names></string-name>. <article-title>Nucleus basalis (Ch4) and cortical cholinergic innervation in the human brain: observations based on the distribution of acetylcholinesterase and choline acetyltransferase</article-title>. <source><italic toggle="yes">J Comp Neurol</italic></source>. <year>1988</year>;<volume>275</volume>(<issue>2</issue>):<fpage>216</fpage>–<lpage>240</lpage>. doi:<pub-id pub-id-type="doi">10.1002/cne.902750205</pub-id><pub-id pub-id-type="pmid">3220975</pub-id></mixed-citation>
      </ref>
      <ref id="cit0038">
        <label>38.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Selden</surname>
<given-names>NR</given-names></string-name>, <string-name><surname>Gitelman</surname>
<given-names>DR</given-names></string-name>, <string-name><surname>Salamon-Murayama</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Parrish</surname>
<given-names>TB</given-names></string-name>, <string-name><surname>Mesulam</surname>
<given-names>MM</given-names></string-name>. <article-title>Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain</article-title>. <source><italic toggle="yes">Brain</italic></source>. <year>1998</year>;<volume>121</volume>(<issue>Pt 12</issue>):<fpage>2249</fpage>–<lpage>2257</lpage>. doi:<pub-id pub-id-type="doi">10.1093/brain/121.12.2249</pub-id><pub-id pub-id-type="pmid">9874478</pub-id></mixed-citation>
      </ref>
      <ref id="cit0039">
        <label>39.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Ishii</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Nishihara</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Imamura</surname>
<given-names>T</given-names></string-name>. <article-title>Why do frontal lobe symptoms predominate in vascular dementia with lacunes?</article-title>
<source><italic toggle="yes">Neurology</italic></source>. <year>1986</year>;<volume>36</volume>(<issue>3</issue>):<fpage>340</fpage>–<lpage>345</lpage>. doi:<pub-id pub-id-type="doi">10.1212/WNL.36.3.340</pub-id><pub-id pub-id-type="pmid">3951700</pub-id></mixed-citation>
      </ref>
      <ref id="cit0040">
        <label>40.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Basta</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Koutentaki</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Vgontzas</surname>
<given-names>A</given-names></string-name>, et al. <article-title>Objective daytime napping is associated with disease severity and inflammation in patients with mild to moderate dementia1</article-title>. <source><italic toggle="yes">J Alzheimers Dis</italic></source>. <year>2020</year>;<volume>74</volume>(<issue>3</issue>):<fpage>803</fpage>–<lpage>815</lpage>. doi:<pub-id pub-id-type="doi">10.3233/JAD-190483</pub-id><pub-id pub-id-type="pmid">32116246</pub-id></mixed-citation>
      </ref>
      <ref id="cit0041">
        <label>41.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Prins</surname>
<given-names>ND</given-names></string-name>, <string-name><surname>Scheltens</surname>
<given-names>P</given-names></string-name>. <article-title>White matter hyperintensities, cognitive impairment and dementia: an update</article-title>. <source><italic toggle="yes">Nat Rev Neurol</italic></source>. <year>2015</year>;<volume>11</volume>(<issue>3</issue>):<fpage>157</fpage>–<lpage>165</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrneurol.2015.10</pub-id><pub-id pub-id-type="pmid">25686760</pub-id></mixed-citation>
      </ref>
      <ref id="cit0042">
        <label>42.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Debette</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Markus</surname>
<given-names>HS</given-names></string-name>. <article-title>The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis</article-title>. <source><italic toggle="yes">BMJ</italic></source>. <year>2010</year>;<volume>341</volume>:<fpage>c3666</fpage>. doi:<pub-id pub-id-type="doi">10.1136/bmj.c3666</pub-id><pub-id pub-id-type="pmid">20660506</pub-id></mixed-citation>
      </ref>
      <ref id="cit0043">
        <label>43.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Werring</surname>
<given-names>DJ</given-names></string-name>, <string-name><surname>Frazer</surname>
<given-names>DW</given-names></string-name>, <string-name><surname>Coward</surname>
<given-names>LJ</given-names></string-name>, et al. <article-title>Cognitive dysfunction in patients with cerebral microbleeds on T2*-weighted gradient-echo MRI</article-title>. <source><italic toggle="yes">Brain</italic></source>. <year>2004</year>;<volume>127</volume>(<issue>Pt 10</issue>):<fpage>2265</fpage>–<lpage>2275</lpage>. doi:<pub-id pub-id-type="doi">10.1093/brain/awh253</pub-id><pub-id pub-id-type="pmid">15282216</pub-id></mixed-citation>
      </ref>
      <ref id="cit0044">
        <label>44.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Ding</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Sigurethsson</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Jonsson</surname>
<given-names>PV</given-names></string-name>, et al. <article-title>Space and location of cerebral microbleeds, cognitive decline, and dementia in the community</article-title>. <source><italic toggle="yes">Neurology</italic></source>. <year>2017</year>;<volume>88</volume>(<issue>22</issue>):<fpage>2089</fpage>–<lpage>2097</lpage>. doi:<pub-id pub-id-type="doi">10.1212/WNL.0000000000003983</pub-id><pub-id pub-id-type="pmid">28468844</pub-id></mixed-citation>
      </ref>
      <ref id="cit0045">
        <label>45.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Ding</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Sigurethsson</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Jonsson</surname>
<given-names>PV</given-names></string-name>, et al. <article-title>Large perivascular spaces visible on magnetic resonance imaging, cerebral small vessel disease progression, and risk of dementia: the Age, Gene/Environment Susceptibility-Reykjavik Study</article-title>. <source><italic toggle="yes">JAMA Neurol</italic></source>. <year>2017</year>;<volume>74</volume>(<issue>9</issue>):<fpage>1105</fpage>–<lpage>1112</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jamaneurol.2017.1397</pub-id><pub-id pub-id-type="pmid">28715552</pub-id></mixed-citation>
      </ref>
      <ref id="cit0046">
        <label>46.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Hilal</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Mok</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Youn</surname>
<given-names>YC</given-names></string-name>, <string-name><surname>Wong</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Ikram</surname>
<given-names>MK</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>CL</given-names></string-name>. <article-title>Prevalence, risk factors and consequences of cerebral small vessel diseases: data from three Asian countries</article-title>. <source><italic toggle="yes">J Neurol Neurosurg Psychiatry</italic></source>. <year>2017</year>;<volume>88</volume>(<issue>8</issue>):<fpage>669</fpage>–<lpage>674</lpage>. doi:<pub-id pub-id-type="doi">10.1136/jnnp-2016-315324</pub-id><pub-id pub-id-type="pmid">28600443</pub-id></mixed-citation>
      </ref>
      <ref id="cit0047">
        <label>47.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Merlino</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Piani</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Gigli</surname>
<given-names>GL</given-names></string-name>, et al. <article-title>Daytime sleepiness is associated with dementia and cognitive decline in older Italian adults: a population-based study</article-title>. <source><italic toggle="yes">Sleep Med</italic></source>. <year>2010</year>;<volume>11</volume>(<issue>4</issue>):<fpage>372</fpage>–<lpage>377</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.sleep.2009.07.018</pub-id><pub-id pub-id-type="pmid">20219426</pub-id></mixed-citation>
      </ref>
      <ref id="cit0048">
        <label>48.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Tsapanou</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Gu</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Manly</surname>
<given-names>J</given-names></string-name>, et al. <article-title>Daytime sleepiness and sleep inadequacy as risk factors for dementia</article-title>. <source><italic toggle="yes">Dement Geriatr Cogn Dis Extra</italic></source>. <year>2015</year>;<volume>5</volume>(<issue>2</issue>):<fpage>286</fpage>–<lpage>295</lpage>. doi:<pub-id pub-id-type="doi">10.1159/000431311</pub-id><pub-id pub-id-type="pmid">26273244</pub-id></mixed-citation>
      </ref>
      <ref id="cit0049">
        <label>49.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Nakakubo</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Doi</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Makizako</surname>
<given-names>H</given-names></string-name>, et al. <article-title>Sleep condition and cognitive decline in Japanese community-dwelling older people: data from a 4-year longitudinal study</article-title>. <source><italic toggle="yes">J Sleep Res</italic></source>. <year>2019</year>;<volume>28</volume>(<issue>4</issue>):<fpage>e12803</fpage>. doi:<pub-id pub-id-type="doi">10.1111/jsr.12803</pub-id><pub-id pub-id-type="pmid">30537088</pub-id></mixed-citation>
      </ref>
      <ref id="cit0050">
        <label>50.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Endeshaw</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Rice</surname>
<given-names>TB</given-names></string-name>, <string-name><surname>Schwartz</surname>
<given-names>AV</given-names></string-name>, et al. <article-title>Snoring, daytime sleepiness, and incident cardiovascular disease in the health, aging, and body composition study</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2013</year>;<volume>36</volume>(<issue>11</issue>):<fpage>1737</fpage>–<lpage>1745</lpage>. doi:<pub-id pub-id-type="doi">10.5665/sleep.3140</pub-id><pub-id pub-id-type="pmid">24179308</pub-id></mixed-citation>
      </ref>
      <ref id="cit0051">
        <label>51.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Zhang</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Jiang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>Y</given-names></string-name>, et al. <article-title>Associations of arterial stiffness and carotid atherosclerosis with cerebral small vessel disease in a rural community-based population</article-title>. <source><italic toggle="yes">J Atheroscler Thromb</italic></source>. <year>2020</year>;<volume>27</volume>(<issue>9</issue>):<fpage>922</fpage>–<lpage>933</lpage>. doi:<pub-id pub-id-type="doi">10.5551/jat.52530</pub-id><pub-id pub-id-type="pmid">32037371</pub-id></mixed-citation>
      </ref>
      <ref id="cit0052">
        <label>52.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Rensma</surname>
<given-names>SP</given-names></string-name>, <string-name><surname>van Sloten</surname>
<given-names>TT</given-names></string-name>, <string-name><surname>Launer</surname>
<given-names>LJ</given-names></string-name>, <string-name><surname>Stehouwer</surname>
<given-names>CDA</given-names></string-name>. <article-title>Cerebral small vessel disease and risk of incident stroke, dementia and depression, and all-cause mortality: a systematic review and meta-analysis</article-title>. <source><italic toggle="yes">Neurosci Biobehav Rev</italic></source>. <year>2018</year>;<volume>90</volume>:<fpage>164</fpage>–<lpage>173</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neubiorev.2018.04.003</pub-id><pub-id pub-id-type="pmid">29656031</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
